Skip to main content
Quest PharmaTech Inc. logo

Quest PharmaTech Inc. — Investor Relations & Filings

Ticker · QPT ISIN · CA74836M1068 TSXV Manufacturing
Filings indexed 107 across all filing types
Latest filing 2023-05-31 Regulatory Filings
Country CA Canada
Listing TSXV QPT

About Quest PharmaTech Inc.

https://questpharmatech.com/

Quest PharmaTech Inc. is a biopharmaceutical company focused on the discovery and development of novel therapeutics. The company's pipeline targets applications in cancer treatment, dermatology, and wound healing, utilizing both proprietary technologies, such as transdermal delivery systems, and strategic investments. A core proprietary asset is the antibody Mab AR 9.6, licensed for targeted cancer therapy against truncated O-glycan on MUC16. Quest also maintains significant ownership interests in associated entities, including OncoVent, and holds convertible bond interests in OncoQuest Pharmaceuticals, Inc. (OQP). These OQP bonds are planned to be exchanged into shares of Canaria Bio, a company developing immunotherapy assets, providing Quest with an expected ownership stake of approximately 23% in Canaria Bio upon conversion.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-05-31 English
Audited annual financial statements – English.pdf
Regulatory Filings
2023-05-31 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-05-12 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-12-20 English
Interim MD&A - English.pdf
Regulatory Filings
2022-12-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.